The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats

被引:120
作者
Gao, Ying [1 ,2 ]
Zou, Shujuan [1 ,2 ]
Liu, Xiaoguang [3 ]
Bao, Chongyun [1 ,2 ,3 ]
Hu, Jing [1 ,2 ]
机构
[1] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610041, Peoples R China
[2] Sichuan Univ, Dept Oral & Maxillofacial Surg, Chengdu 610041, Peoples R China
[3] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610044, Peoples R China
关键词
Bisphosphonate; Immobilize; Hydroxyapatite; Implant; Osteoporosis; TOTAL HIP-ARTHROPLASTY; JOINT REPLACEMENT; BONE-RESORPTION; IN-VITRO; OSTEOPOROSIS; PAMIDRONATE; DELIVERY; OSTEOARTHRITIS; NECROSIS; CELLS;
D O I
10.1016/j.biomaterials.2008.12.025
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Immobilized bisphosphonates (BPs) have been introduced to improve implant fixation, however, no information could be found about the efficiency of this approach in osteoporotic bone. This study was designed to evaluate the bone response to surface immobilized BPs on implants inserted in tibiae of ovariectomized (OVX) rats. Three months after bilateral ovariectomy, 40 rats were randomly assigned into four groups for implantation of hydroxyapatite-coated titanium implants with or without immobilized BPs: (1) control group (without BP treatments); (2) pamidronate (PAM) group (1 mg/ml of PAM immersing); (3) ibandronate group (1 mg/ml of ibandronate immersing); and (4) zoledronic acid (ZOL) group (1 mg/ml of ZOL immersing). After implantation periods of 3 months, the peri-implant-bone density, trabecular microstructure, bone-implant interface and mechanical fixation of implants were evaluated by dual energy X-ray absorptiometry, micro-computed tomography, histology and push-out test. We found that three BPs triggered pronounced bone-implant integration and early bone formation around implants in OVX rats, with a rank order of ZOL > ibandronate > PAM. These results provide new evidence that immobilized BPs have positive effects on implant fixation in osteoporotic bone, in addition to their well-documented potency to inhibit implant loosening in normal bone. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1790 / 1796
页数:7
相关论文
共 30 条
[1]  
Åkesson K, 2003, B WORLD HEALTH ORGAN, V81, P657
[2]   Cernentless double-tapered total hip arthroplasty in patients 75 years of age and older [J].
Berend, KR ;
Lombardi, AV ;
Mallory, TH ;
Dodds, KL ;
Adams, JB .
JOURNAL OF ARTHROPLASTY, 2004, 19 (03) :288-295
[3]   Anti-osteoporotic medications: Traditional and nontraditional [J].
Cohen, DP .
CLINICAL OBSTETRICS AND GYNECOLOGY, 2003, 46 (02) :341-348
[4]  
Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235
[5]   Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption [J].
Ezra, A ;
Golomb, G .
ADVANCED DRUG DELIVERY REVIEWS, 2000, 42 (03) :175-195
[6]   Parathyroid hormone 1-34 enhances titanium implant anchorage in low-density trabecular bone:: A correlative micro-computed tomographic and biomechanical analysis [J].
Gabet, Yankel ;
Mueller, Ralph ;
Levy, Jay ;
Dimarchi, Richard ;
Chorev, Michael ;
Bab, Itai ;
Kohavi, David .
BONE, 2006, 39 (02) :276-282
[7]   Osteoporosis and vitamin-D deficiency among postmenopausal women with osteoarthritis undergoing total hip arthroplasty [J].
Glowacki, J ;
Hurwitz, S ;
Thornhill, TS ;
Kelly, M ;
LeBoff, MS .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2003, 85A (12) :2371-2377
[8]   The bisphosphonate pamidronate on the surface of titanium stimulates bone formation around tibial implants in rats [J].
Kajiwara, H ;
Yamaza, T ;
Yoshinari, M ;
Goto, T ;
Iyama, S ;
Atsuta, I ;
Kido, MA ;
Tanaka, T .
BIOMATERIALS, 2005, 26 (06) :581-587
[9]  
KINNEY JH, 1996, SCI TECHNOL REV, V6, P22
[10]   CLINICAL ASPECTS OF OSSEOINTEGRATION IN JOINT REPLACEMENT - A HISTOLOGICAL STUDY OF TITANIUM IMPLANTS [J].
LINDER, L ;
CARLSSON, A ;
MARSAL, L ;
BJURSTEN, LM ;
BRANEMARK, PI .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1988, 70 (04) :550-555